Invitrogen™ Peptide synthétique LGI2 humain
LGI2 Synthetic Peptide, PEP-0612, from Invitrogen.
- Gene ID (Entrez)
- 55203
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- Q8N0V4
- Nom usuel
- Human LGI2
- Marque
- Invitrogen
LGI2 Synthetic Peptide, PEP-0612, from Invitrogen.
LGI2 Synthetic Peptide, PEP-0612, from Invitrogen.
The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15348770 |
| Caractéristiques | |
| Gene ID (Entrez) | 55203 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q8N0V4 |
| Nom usuel | Human LGI2 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | LGI2 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-0612 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 92 00 |